Marashi–Gorlin syndrome

Marashi–Gorlin syndrome is a rare genetic disorder characterized by a combination of medical and physical anomalies. This syndrome is also known as orofaciodigital syndrome type I (OFD1), highlighting its primary manifestations in the oral cavity, face, and digits. The condition is named after the researchers who first described it in detail.

Symptoms and Characteristics

Marashi–Gorlin syndrome presents a wide range of symptoms, which can vary significantly among affected individuals. Common features include:

• Oral Manifestations: Individuals with Marashi–Gorlin syndrome often have dental anomalies, such as extra (supernumerary) teeth or missing teeth (hypodontia). Cleft lip and/or cleft palate are also common, along with a high-arched palate.
• Facial Features: Distinctive facial features may include a broad nasal bridge, hypertelorism (widely spaced eyes), and micrognathia (a small jaw).
• Digital Anomalies: The syndrome often involves abnormalities in the fingers and toes, such as syndactyly (webbing), polydactyly (extra digits), and brachydactyly (short digits).
• Neurological Issues: Some individuals may experience developmental delays or intellectual disability.

Genetics

Marashi–Gorlin syndrome is primarily inherited in an X-linked dominant manner, which means the gene responsible for the condition is located on the X chromosome. Females are typically more affected than males, and the condition can be lethal in males before birth. The gene implicated in this syndrome is OFD1, which plays a crucial role in the development and function of primary cilia, cellular structures important for signaling pathways during development.

Diagnosis

Diagnosis of Marashi–Gorlin syndrome is based on clinical evaluation and the identification of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the OFD1 gene. Prenatal testing may be available for families with a known mutation.

Treatment and Management

There is no cure for Marashi–Gorlin syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary team including dentists, orthodontists, surgeons, speech therapists, and other specialists to address the various manifestations of the syndrome. Regular monitoring and supportive care can help manage symptoms and improve quality of life.

Prognosis

The prognosis for individuals with Marashi–Gorlin syndrome varies depending on the severity of symptoms. With appropriate management, many individuals can lead relatively normal lives. However, severe cases, especially those with significant neurological involvement, may have a more guarded prognosis.

   This article is a  stub. You can help WikiMD by expanding it!